Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Receivables - Other (2018 - 2025)

Historic Receivables - Other for American Healthcare REIT (AHR) over the last 8 years, with Q3 2025 value amounting to $169.0 million.

  • American Healthcare REIT's Receivables - Other rose 38.79% to $169.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.0 million, marking a year-over-year increase of 38.79%. This contributed to the annual value of $167.0 million for FY2024, which is 1260.75% up from last year.
  • Latest data reveals that American Healthcare REIT reported Receivables - Other of $169.0 million as of Q3 2025, which was up 38.79% from $177.5 million recorded in Q2 2025.
  • American Healthcare REIT's Receivables - Other's 5-year high stood at $177.5 million during Q1 2025, with a 5-year trough of $1.0 million in Q2 2021.
  • Its 5-year average for Receivables - Other is $119.6 million, with a median of $122.4 million in 2023.
  • Its Receivables - Other has fluctuated over the past 5 years, first plummeted by 6898.41% in 2021, then surged by 1030587.73% in 2022.
  • Quarter analysis of 5 years shows American Healthcare REIT's Receivables - Other stood at $94.9 million in 2021, then increased by 28.5% to $122.0 million in 2022, then rose by 21.55% to $148.3 million in 2023, then increased by 12.61% to $167.0 million in 2024, then grew by 1.21% to $169.0 million in 2025.
  • Its Receivables - Other stands at $169.0 million for Q3 2025, versus $177.5 million for Q2 2025 and $177.5 million for Q1 2025.